Abstract
Migraine is a chronic paroxysmal neurological disorder characterised by multiphase attacks of head pain and a myriad of neurological symptoms. The underlying genetic and biological underpinnings and neural networks involved are coming sharply into focus. This progress in the fundamental understanding of migraine has led to novel, mechanism-based and disease-specific therapeutics. In this Seminar, the clinical features and neurobiology of migraine are reviewed, evidence to support available treatment options is provided, and emerging drug, device, and biological therapies are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 1315-1330 |
Number of pages | 16 |
Journal | The Lancet |
Volume | 391 |
Issue number | 10127 |
DOIs | |
State | Published - Mar 31 2018 |
ASJC Scopus subject areas
- Medicine(all)